Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2025-12-26 @ 1:44 PM
Study NCT ID:
NCT06886893
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-03-20
First Post:
2025-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Optical Coherence Tomography in Retinal Vein Occlusion
Sponsor:
Assiut University
Organization:
Study Overview
Official Title:
Optical Coherence Tomography Data As a Prognostic Indicator in Retinal Vein Occlusion
Status:
NOT_YET_RECRUITING
Status Verified Date:
2025-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate how optical coherence tomography (OCT) can help predict outcomes in patients with retinal vein occlusion (RVO), a condition that affects blood flow in the retina. RVO can cause macular edema, which is swelling in the part of the eye responsible for central vision. The study will use OCT scans to assess changes in the retina and how these changes relate to vision improvement over time.
Detailed Description:
Objectives Evaluate how OCT data can predict visual outcomes by analyzing retinal changes and macular edema characteristics.
Assess the correlation between baseline OCT biomarkers and visual acuity improvements over time.
Study Design Type: Cross-sectional study.
Setting: Conducted at several eye care centers in Egypt.
Participants Inclusion Criteria: Adults with branch or central RVO, macular edema confirmed by OCT, and no prior RVO in the affected eye.
Exclusion Criteria: Other retinal diseases, recent intraocular surgery, or significant media opacities.
Procedures Informed Consent and History Taking.
Ophthalmologic Examination: Includes BCVA, IOP, slit-lamp biomicroscopy, and fundus examination.
OCT Imaging: Using NIDEK RS-330 Retina scan duo 2 (SD-OCT) to assess macular changes.
OCT Image Evaluation: Classification of macular edema types and assessment of biomarkers like subretinal fluid and cystoid changes.
Assess the correlation between baseline OCT biomarkers and visual acuity improvements over time.
Study Design Type: Cross-sectional study.
Setting: Conducted at several eye care centers in Egypt.
Participants Inclusion Criteria: Adults with branch or central RVO, macular edema confirmed by OCT, and no prior RVO in the affected eye.
Exclusion Criteria: Other retinal diseases, recent intraocular surgery, or significant media opacities.
Procedures Informed Consent and History Taking.
Ophthalmologic Examination: Includes BCVA, IOP, slit-lamp biomicroscopy, and fundus examination.
OCT Imaging: Using NIDEK RS-330 Retina scan duo 2 (SD-OCT) to assess macular changes.
OCT Image Evaluation: Classification of macular edema types and assessment of biomarkers like subretinal fluid and cystoid changes.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: